Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 26:16:1618677.
doi: 10.3389/fimmu.2025.1618677. eCollection 2025.

HuR ablation destabilizes Foxp3 mRNA and impairs regulatory T cell function, contributing to an autoimmune phenotype

Affiliations

HuR ablation destabilizes Foxp3 mRNA and impairs regulatory T cell function, contributing to an autoimmune phenotype

Fatemeh Fattahi et al. Front Immunol. .

Abstract

Introduction: The RNA-binding protein HuR (Elavl1), a key post-transcriptional regulator, plays a critical role in T cell activation and function by stabilizing target mRNAs. To investigate the role of HuR in regulatory T cell (Treg) function, we generated the Foxp3YFP/Cre HuRfl/fl mouse model.

Methods: In this model, homozygous females and hemizygous males for Foxp3 developed a scurfy-like phenotype displaying autoimmune features, including failure to thrive, splenomegaly, hair loss, tail stippling, and widespread multi-organ immune cell infiltration. Molecular analysis included direct interaction studies between HuR and Foxp3 mRNA to assess mRNA stability, RNA sequencing of YFP⁺ Tregs, Protein-Protein Interaction (PPI) analysis, qPCR, and Treg functional assays.

Results: To our knowledge, this is the first study demonstrating that HuR directly binds and stabilizes Foxp3 mRNA in Tregs, using a novel Treg-specific HuR-deficient mouse model, with implications for autoimmune regulation. Foxp3 mRNA stability and expression were significantly reduced in Tregs from these HuR KO mice, despite higher frequencies of YFP⁺ Tregs. RNA sequencing revealed significant dysregulation of several pathways, including the T helper differentiation pathway, in which Foxp3 played a central role. PPI analysis showed a direct link between Foxp3 and Rorc (encoding RORγt), connecting Foxp3 to the T cell differentiation pathway via IL-23R. Our qPCR analysis supported these findings. Functional assays demonstrated a reduction in the suppressive capacity of HuR-deficient Tregs.

Conclusion: These findings together suggest that ablation of HuR in Tregs disrupts Foxp3 expression and Treg function, likely through dysregulation of T cell differentiation pathways involving RORγt. This potentially contributes to a disrupted Treg-Th17 axis and autoimmune dysfunction. These data suggest that HuR-mediated post-transcriptional regulation contributes to maintaining Foxp3 expression and immune homeostasis, although compensatory mechanisms such as increased IL-10 expression may also be involved.

Keywords: Foxp3 stability; HuR (ELAVL1); IPEX syndrome; RNA-binding proteins (RBPs); RORγt (Rorc); post-transcriptional regulation; regulatory T cells (Tregs); systemic autoimmunity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Treg-specific ablation of HuR in Foxp3 YFP/Cre HuR fl/fl mice results in severe failure to thrive (FTT) and systemic spontaneous autoimmunity. (A) Schematic illustrating conditional deletion of HuR in Tregs in the Foxp3 YFP/Cre , HuR fl/fl (HuR-KO Tregs) mouse model. (B) Western blot of HuR protein in sorted YFP+ (HuR-null) versus YFP Treg populations showing near-complete HuR deletion in YFP+ cells, with β-actin as loading control. (C) Quantification of HuR/β-actin protein levels from western blots, showing HuR reduction in YFP+ Tregs compared to controls. (D) Bar graph of HuR mean fluorescence intensity (MFI) in YFP+ versus YFP Tregs and isotype control, showing significant HuR reduction in YFP+ Tregs (mean ± SD, p < 0.05 by unpaired t-test, n = 4). (E) Flow cytometry histogram representative showing HuR expression profiles in YFP+, YFP, and isotype control populations. (F) Body weight monitored from 3–26 weeks in male and female Foxp3 YFP/Cre , HuR fl/fl (open symbols) versus controls (solid symbols). Both male and female HuR-deficient mice exhibited severe growth impairment (males plateaued at 18.5 ± 1.2 g vs. 31.5 ± 1.6 g in controls, p < 0.01; females plateaued at 18.3 ± 1.0 g vs. 26.5 ± 2.4 g in controls, p < 0.05). Two-way repeated measures ANOVA showed significant genotype effect. (G) Clinical phenotype in Foxp3 YFP/Cre , HuR fl/fl mice including splenomegaly, alopecia, and tail stippling. (H) Representative H&E lung section from Foxp3 YFP/Cre , HuR fl/fl mice demonstrating perivascular and peribronchiolar lymphoplasmacytic infiltrates, acidophilic macrophage pneumonia, and hyaline droplets in bronchiolar epithelium. Representative data are shown from at least 8 mice for panels F-H. The age of the mice at the time of analysis was 6–7 months. *p<0.05, **p<0.01.
Figure 2
Figure 2
HuR directly interacts with Foxp3 mRNA and controls its steady-state levels and mRNA stability. (A) Foxp3 mRNA stability was evaluated in splenic Tregs (CD4+CD25+) isolated by magnetic column separation from WT mice treated with KH-3 or sham control (KH3-B) for 2 hours, followed by actinomycin (D) HuR inhibition reduced Foxp3 mRNA half-life (1.9 hours with KH-3) compared to control (4.3 hours). Data represents seven WT mice. (B) Foxp3 mRNA stability was assessed in column-isolated splenic Tregs from WT and Foxp3 YFP/Cre HuR fl/fl (HuR-KO Tregs) mice. HuR-KO Tregs showed a shorter Foxp3 mRNA half-life (1.9 hours) compared to WT (4.2 hours). Data represents seven WT and four HuR-KO mice. (C) Steady-state Foxp3 mRNA levels were measured in splenic and thymic Tregs. Foxp3 mRNA was significantly lower in HuR-KO Tregs compared to WT control, while CD4+CD25 cells showed minimal expression with no significant differences. Data represent three HuR-KO and three WT mice. (D) RNA immunoprecipitation (RIP) from WT splenic Tregs showed Foxp3 mRNA enrichment in HuR pull-downs compared to IgG1 control, with β-actin as a positive control. Each point represents pooled cells from four WT mice. A total of 12 mice were used across three independent experiments. **p<0.01, ****p<0.0001.
Figure 3
Figure 3
Gene profiling of RNA-seq and PPI analysis reveals direct interaction between Rorc and Foxp3 in HuR-KO Tregs in Foxp3 YFP/Cre HuR fl/fl Tregs. (A) Volcano plot visualization of RNA-Seq results from sorted YFP+ (HuR-KO Tregs) isolated from the spleen of Foxp3 YFP/Cre HuR fl/fl mice. The plot shows the expression levels of 2220 statistically significant genes in YFP+ (HuR-KO Tregs), with differentially expressed genes highlighted (upregulated in red, downregulated in blue). FOXP3, Rorc, and IL-23R, were identified and labeled. (B) Protein-protein interaction (PPI) network analysis using Cytoscape identified significant gene interactions. Among the differentially expressed genes in YFP+ (HuR-KO Tregs), Rorc (RORγt) was found to directly interact with FOXP3, as shown in the enlarged region (red dashed box). n = 6 mice.
Figure 4
Figure 4
Altered mRNA expression of selected genes involved in T helper differentiation and Treg function in Foxp3 YFP/Cre HuR fl/fl Tregs compared to WT control Tregs. (A-F) mRNA expression of key genes involved in T helper differentiation (based on RNA-seq IPA analysis) and Treg function including Rorc, Il23r, Ctla4, Il2r, Il10 and Il17a was measured by qPCR in CD4+CD25+ Tregs isolated from the spleens of HuR-KO and WT control mice, following 4 days of activation with anti-CD3 and anti-CD28. Data were analyzed using unpaired Student’s t-test. Results are representative of four independent HuR-KO mice and a total of six corresponding WT controls, from cohorts distinct from those used in RNA-seq analysis.
Figure 5
Figure 5
Impaired suppressive function of HuR-KO Tregs (Foxp3 YFP/Cre HuR fl/fl ) on Teffector cell proliferation. The in vitro suppressive ability of Tregs in regulating Teffector cell (Teff) proliferation was evaluated by flow cytometry. Teff cells were labeled with a proliferation dye prior to co-culture with isolated Tregs (CD4+CD25+) from control HuR fl/fl WT (blue bars) and Foxp3 YFP/Cre HuR fl/fl (red bars) mice at varying Treg: Teff ratios, as indicated on the x-axis. (A) Percentage suppression of Teff cell proliferation by CD4+CD25+ Tregs across different Treg: Teff ratios. HuR-KO Tregs showed a significant, progressive decline in suppressive capacity beginning at the 1:64 ratio, whereas WT Tregs maintained stable suppression even at lower Treg frequencies. (B) Representative flow cytometry histograms of Teff proliferation patterns (gated on live cells), demonstrating reduced suppression by HuR-KO Tregs compared to WT Tregs. Overall, HuR-KO Tregs exhibited significantly reduced suppression of Teff cell proliferation (p < 0.0001). Data are from five mice per group, each run-in duplicate. Data were analyzed using two-way ANOVA followed by Šídák’s multiple comparisons test. *p<0.05; **p<0.01.

References

    1. Sakaguchi S, Vignali DA, Rudensky AY, Niec RE, Waldmann H. The plasticity and stability of regulatory T cells. Nat Rev Immunol. (2013) 13:461–7. doi: 10.1038/nri3464, PMID: - DOI - PubMed
    1. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+ss+ regulatory T cells. Nat Immunol. (2003) 4:330–6. doi: 10.1038/ni904, PMID: - DOI - PubMed
    1. Hill JA, Feuerer M, Tash K, Haxhinasto S, Perez J, Melamed R, et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity. (2007) 27:786–800. doi: 10.1016/j.immuni.2007.09.010, PMID: - DOI - PubMed
    1. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. (2003) 299:1057–61. doi: 10.1126/science.1079490, PMID: - DOI - PubMed
    1. Clark LB, Appleby MW, Brunkow ME, Wilkinson JE, Ziegler SF, Ramsdell F. Cellular and molecular characterization of the scurfy mouse mutant. J Immunol. (1999) 162:2546–54. doi: 10.4049/jimmunol.162.5.2546, PMID: - DOI - PubMed

MeSH terms